Efficacy and safety of zoledronic acid in the treatment of osteoporosis: A meta-analysis of randomized controlled trials

Purpose: Zoledronic acid can inhibit the activity of osteoclasts, and thus, may slow or inhibit bone loss. The purpose of this study was to systematically evaluate the efficacy and safety of zoledronic acid in the treatment of osteoporosis. Methods: Four databases, PubMed, Embase, Cochrane Library,...

Full description

Bibliographic Details

Published in:	Heliyon
Main Authors:	Jianfeng Sun, Masoud Rahmati, Wenqing Xie, Guang Yang, Bingzhou Ji, Dong Keon Yon, Seung Won Lee, Razak M. Gyasi, Guillermo F. López Sánchez, Pinar Soysal, Ai Koyanagi, Lee Smith, Jae Il Shin, Yusheng Li
Format:	Article
Language:	English
Published:	Elsevier 2024-07-01
Subjects:	Zoledronic acid Osteoporosis BMD Efficacy Safety
Online Access:	http://www.sciencedirect.com/science/article/pii/S240584402409902X